CymaBay Therapeutics Inc. (CBAY)

Ratios and Metrics (Annual)

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	331	233	395	135	468	404	41	40	144
Market Cap Growth	-	-40.98%	193.65%	-71.21%	15.92%	894.86%	2.37%	-72.55%	-
Enterprise Value	250	98	250	-55	289	312	32	7	114
PE Ratio	-	-2.59	-7.75	-1.31	-6.45	-14.64	-1.52	-2.55	-4.52
PS Ratio	-	-	-	-	-	40.35	-	-	-
PB Ratio	4.01	1.76	2.77	0.72	2.75	4.75	10.30	1.41	10.42
EV/Sales Ratio	-	-	-	-	-	38.74	-	-	-
Debt / Equity Ratio	1.00	0.38	0.01	0.01	-	0.07	2.24	0.33	0.33
Debt / EBITDA Ratio	-0.88	-0.59	-0.02	-0.02	-	-0.23	-0.35	-0.64	-0.14
Debt / FCF Ratio	-1.07	-0.73	-0.03	-0.02	-	-0.31	-0.38	-0.40	-0.21
Current Ratio	13.27	10.41	15.38	11.51	12.60	6.35	1.99	6.88	1.82
Asset Turnover	-	0	0	0	0	0.16	0	0	0
Return on Equity (ROE)	-101.60%	-79.20%	-31.90%	-46.10%	-37.70%	-60.30%	-207.50%	-63.70%	-213.40%
Return on Assets (ROA)	-59.20%	-62.20%	-29.70%	-42.60%	-34.50%	-43.60%	-95.80%	-40.00%	-91.60%
Return on Capital (ROIC)	-67.20%	-103.40%	-48.20%	-60.00%	-49.60%	-66.60%	-152.90%	-52.90%	-360.60%
Earnings Yield	-31.40%	-38.60%	-12.90%	-76.30%	-15.50%	-6.80%	-65.80%	-39.20%	-22.10%
FCF Yield	-23.40%	-29.80%	-11.30%	-72.90%	-11.90%	-4.90%	-57.70%	-58.90%	-14.70%
Buyback Yield / Dilution	-27.28%	-3.14%	-2.77%	-15.90%	-65.71%	-48.86%	-23.95%	-57.00%	-323.42%
Total Shareholder Return	-27.28%	-3.14%	-2.77%	-15.90%	-65.71%	-48.86%	-23.95%	-57.00%	-323.42%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).